Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02393885 · ClinicalTrials.gov registry record · NA
Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach
A NA study, sponsored by AtriCure.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT02393885: Completed NA study, sponsored by AtriCure.
NCT02393885 is a NA study that has completed, run by AtriCure. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02393885, a NA study, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The objective of this study is to establish the safety and effectiveness of a dual epicardial and endocardial ablation procedure for patients presenting with Persistent Atrial Fibrillation or Longstanding Persistent Atrial Fibrillation
Primary Outcome
Freedom from any documented AF, atrial flutter, or atrial tachycardia lasting \>30 seconds in duration through the 12 month follow-up visit in the absence of Class I or III AADs (with the exception of previously failed AADs at doses not exceeding those previously failed).
Interventions
- DEVICE AtriCure Bipolar System and AtriClip® PRO LAA Exclusion System, Endocardial Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2015-02 |
| Est. Completion | 2024-04-17 |
| Phase | NA |
What the finished NCT02393885 record still lists
NCT02393885 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which AtriCure Bipolar System and AtriClip® PRO LAA Exclusion System, Endocardial Ablation is the first listed.
NCT02393885 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02393885 about?
NCT02393885 is a clinical study titled "Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach". The objective of this study is to establish the safety and effectiveness of a dual epicardial and endocardial ablation procedure for patients presenting with Persistent Atrial Fibrillation or Longstanding Persistent Atrial Fibrillation
What is the current status of trial NCT02393885?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2015-02. Estimated completion is 2024-04-17.
What interventions are being tested in trial NCT02393885?
The interventions under investigation include: AtriCure Bipolar System and AtriClip® PRO LAA Exclusion System, Endocardial Ablation (DEVICE).
Who is sponsoring clinical trial NCT02393885?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02393885's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia